APA (7th ed.) Citation

Bäumer, N., Scheller, A., Wittmann, L., Faust, A., Apel, M., Nimmagadda, S. C., . . . Bäumer, S. (2022). Electrostatic anti-CD33-antibody-protamine nanocarriers as platform for a targeted treatment of acute myeloid leukemia. Journal of hematology & oncology, 15, . https://doi.org/10.1186/s13045-022-01390-5

Chicago Style (17th ed.) Citation

Bäumer, Nicole, et al. "Electrostatic Anti-CD33-antibody-protamine Nanocarriers as Platform for a Targeted Treatment of Acute Myeloid Leukemia." Journal of Hematology & Oncology 15 (2022). https://doi.org/10.1186/s13045-022-01390-5.

MLA (9th ed.) Citation

Bäumer, Nicole, et al. "Electrostatic Anti-CD33-antibody-protamine Nanocarriers as Platform for a Targeted Treatment of Acute Myeloid Leukemia." Journal of Hematology & Oncology, vol. 15, 2022, https://doi.org/10.1186/s13045-022-01390-5.